ACTA PHARMACEUTICA

ACTA PHARMACEUTICA

ACTA PHARMACEUT
影响因子:1.4
JCR分区:Q4
新锐分区:医学4区
是否综述期刊:N/A
是否预警:不在预警名单内
是否OA:
出版国家/地区:CROATIA
出版社:Sciendo, a De Gruyter company
发刊时间:1951
收录数据库:SCIE/Scopus收录/DOAJ开放期刊
ISSN:1330-0075

期刊介绍

Acta Pharmaceutica (AP) is an international, scientific, multidisciplinary journal, devoted to the pharmaceutical and allied sciences, which contains articles predominantly on core biomedical and health subjects. The aim of AP is to increase the impact of pharmaceutical research in academia, industry and laboratories. With a strong emphasis on quality and originality, AP publishes reports from the discovery of a drug up to clinical practice, in the form of preliminary and short communications, original research papers and reviews. Book reviews are published also. AP is a quarterly, single-blind peer-reviewed journal in biomedicine with fully open access and “early bird” platform. All articles are submitted to scrutinized evaluation and fair judgement. AP above all puts scientific honesty and integrity. To reach the highest standards in publication ethics all the parties (authors, editors, reviewers) are required to behave responsibly and ethically. This implies submittance by authors on an exclusive basis, of only their own and new data; novelty and originality are prioritized. Also, secure handling of confidential data by reviewers and editors is a must. AP is indexed in numerous world top international bibliographic bases, like Clarivate Analytics´s Web of Science® Core Collection (SCI-Expanded, JCR/Science Edition, etc.), EMBASE/Excerpta Medica, MEDLINE/PubMed, Scopus/SCImago, and others. According to SCImago JR it is a Q2 journal (pharmaceutical sciences) with a steadily increasing Clarivate JIF value reaching 2.8 in 2022. Topics covered are: • drug design • molecular modelling/docking studies • pharmaceutical chemistry/medicinal chemistry • drug metabolism • analytics of drugs • pharmaceutical technology/formulation studies/nanosystems/cosmetology • pharmaceutical biotechnology • pharmaceutics/biopharmacy (including pharmacokinetics) and pharmacodynamics • drug delivery/disposition and stability • pharmacognosy andu3000phytopharmacy • pharmacology (clinical and animal) • toxicology • clinical pharmacy • pharmacovigilance • pharmaceutical and clinical biochemistry • pharmaceutical biology with genetics/pharmacogenomics/cell biology • pharmacoepidemiology/pharmacoeconomics/social pharmacy • physical pharmacy • radiopharmaceuticals • medicine (including diagnostics and therapy) • peptide and protein chemistry/protein design
AP是一份国际性的多学科期刊,致力于药学和相关科学,主要包含核心生物医学和健康主题的文章。AP的目的是提高药学研究在学术界、工业界和实验室的影响力。AP非常强调质量和原创性,出版从药物发现到临床实践的报告。涵盖的主题包括:分析学、生物化学、生物制药学、生物技术、细胞生物学、细胞培养、临床药学、药物设计、药物递送、药物处置、药物稳定性、基因技术、医学(包括诊断和治疗) 、药物化学、代谢、分子建模、药理学(临床和动物) 、肽和蛋白质化学、生药学、药物流行病学、药物经济学、药效学和药代动力学、蛋白质设计、放射性药物和毒理学。
年发文量 43
国人发稿量 5.59
国人发文占比 0.13%
自引率 0%
平均录取率容易
平均审稿周期 >12周,或约稿
版面费 EUR900
偏重研究方向 PHARMACOLOGY & PHARMACY-

期刊高被引文献

Core-shell nanofibers as drug delivery systems
来源期刊:Acta PharmaceuticaDOI:10.2478/acph-2019-0014
Sesquiterpenes α-humulene and β-caryophyllene oxide enhance the efficacy of 5-fluorouracil and oxaliplatin in colon cancer cells
来源期刊:Acta PharmaceuticaDOI:10.2478/acph-2019-0003
Transdermal patches: Design and current approaches to painless drug delivery
来源期刊:Acta PharmaceuticaDOI:10.2478/acph-2019-0016
Anticancer effects of olive oil polyphenols and their combinations with anticancer drugs
来源期刊:Acta PharmaceuticaDOI:10.2478/acph-2019-0052
How to assess orodispersible film quality? A review of applied methods and their modifications
来源期刊:Acta PharmaceuticaDOI:10.2478/acph-2019-0018
Metabolic stability and its role in the discovery of new chemical entities
来源期刊:Acta PharmaceuticaDOI:10.2478/acph-2019-0024
Gellan gum and polyvinylpyrrolidone (PVP) as binding agents in extrusion/spheronization pellet formulations
来源期刊:Acta PharmaceuticaDOI:10.2478/acph-2019-0007
Dendrimer functionalized folate-targeted gold nanoparticles for luciferase gene silencing in vitro: A proof of principle study
来源期刊:Acta PharmaceuticaDOI:10.2478/acph-2019-0008
Antithrombotic activity of flavonoids and polyphenols rich plant species
来源期刊:Acta PharmaceuticaDOI:10.2478/acph-2019-0050
Antiproliferative and genotoxic potential of xanthen-3-one derivatives
来源期刊:Acta PharmaceuticaDOI:10.2478/acph-2019-0044
Forced degradation of tacrolimus and the development of a UHPLC method for impurities determination
来源期刊:Acta PharmaceuticaDOI:10.2478/acph-2019-0025
Pancreatic lipase inhibitory activity of selected pharmaceutical agents
来源期刊:Acta PharmaceuticaDOI:10.2478/acph-2019-0010
Synthesis and evaluation of some new 1,3,4-oxadiazoles bearing thiophene, thiazole, coumarin, pyridine and pyridazine derivatives as antiviral agents.
来源期刊:Acta pharmaceuticaDOI:10.2478/ACPH-2019-0015
An overview of structurally diversified anticonvulsant agents
来源期刊:Acta PharmaceuticaDOI:10.2478/acph-2019-0023
Haemostatic activity of butanolic extracts of Lamium album and Lamium purpureum aerial parts
来源期刊:Acta PharmaceuticaDOI:10.2478/acph-2019-0026
Secondary metabolites from the resins of Aloe vera and Commiphora mukul mitigate lipid peroxidation
来源期刊:Acta PharmaceuticaDOI:10.2478/acph-2019-0027
Chemistry and pharmacological diversity of quinoxaline motifs as anticancer agents
来源期刊:Acta PharmaceuticaDOI:10.2478/acph-2019-0013
Effects of annexin A1 on apoptosis and cell cycle arrest in human leukemic cell lines
来源期刊:Acta PharmaceuticaDOI:10.2478/acph-2019-0005
Synthesis and antiplasmodial evaluation of novel mefloquine-based fumardiamides
来源期刊:Acta PharmaceuticaDOI:10.2478/acph-2019-0019
Screening of flavonoid aglycons’ metabolism mediated by the human liver cytochromes P450
来源期刊:Acta PharmaceuticaDOI:10.2478/acph-2019-0039
Quantitative analysis and resolution of pharmaceuticals in the environment using multivariate curve resolution-alternating least squares (MCR-ALS)
来源期刊:Acta PharmaceuticaDOI:10.2478/acph-2019-0011
The antitumor activity of umbelliferone in human renal cell carcinoma via regulation of the p110γ catalytic subunit of PI3Kγ
来源期刊:Acta PharmaceuticaDOI:10.2478/acph-2019-0004
In vitro evaluation of stearylamine cationic nanoemulsions for improved ocular drug delivery
来源期刊:Acta PharmaceuticaDOI:10.2478/acph-2019-0054
Therapeutic bullfrog oil-based nanoemulsion for oral application: Development, characterization and stability
来源期刊:Acta PharmaceuticaDOI:10.2478/acph-2019-0001
Antimicrobial assesment of aroylhydrazone derivatives in vitro
来源期刊:Acta PharmaceuticaDOI:10.2478/acph-2019-0020
Application of medicinal plants in several dermatovenerological entities
来源期刊:Acta PharmaceuticaDOI:10.2478/acph-2019-0045
Miniaturized shake-flask HPLC method for determination of distribution coefficient of drugs used in inflammatory bowel diseases
来源期刊:Acta PharmaceuticaDOI:10.2478/acph-2019-0046
Phenolic compounds of Iris adriatica and their antimycobacterial effects
来源期刊:Acta PharmaceuticaDOI:10.2478/acph-2019-0037
Efficacy and safety of local lysozyme treatment in patients with oral mucositis after chemotherapy and radiotherapy
来源期刊:Acta PharmaceuticaDOI:10.2478/acph-2019-0053
Solubilization of ibuprofen for freeze dried parenteral dosage forms
来源期刊:Acta PharmaceuticaDOI:10.2478/acph-2019-0009
Core-in-cup/liquisol dual tackling effect on azelnidipine buccoadhesive tablet micromeritics, in vitro release, and mucoadhesive strength
来源期刊:Acta PharmaceuticaDOI:10.2478/acph-2019-0022
Inhibitory effect of taspine derivative TAD1822-7 on tumor cell growth and angiogenesis via suppression of EphrinB2 and related signaling pathways
来源期刊:Acta PharmaceuticaDOI:10.2478/acph-2019-0021
Stability-indicating HPLC-PDA assay for simultaneous determination of paracetamol, thiamine and pyridoxal phosphate in tablet formulations
来源期刊:Acta PharmaceuticaDOI:10.2478/acph-2019-0017
Evaluation of phenylethylamine type entactogens and their metabolites relevant to ecotoxicology – a QSAR study
来源期刊:Acta PharmaceuticaDOI:10.2478/acph-2019-0038
The absorption of oral morroniside in rats: In vivo, in situ and in vitro studies
来源期刊:Acta PharmaceuticaDOI:10.2478/acph-2019-0012
Comparison of high-performance thin layer chromatography/UV-densitometry and UV-derivative spectrophotometry for the determination of trimetazidine in pharmaceutical formulations
来源期刊:Acta PharmaceuticaDOI:10.2478/acph-2019-0028
Influence of flavonoids’ lipophilicity on platelet aggregation
来源期刊:Acta PharmaceuticaDOI:10.2478/acph-2019-0040
Evaluation of stability and in vitro wound healing potential of melatonin loaded (lipid enriched) chitosan based microspheres
来源期刊:Acta PharmaceuticaDOI:10.2478/acph-2019-0049
Implementation of medication management services at the primary healthcare level – a pilot study
来源期刊:Acta PharmaceuticaDOI:10.2478/acph-2019-0055
Comparison of clinico-pathological characteristics and survival of recurrent ovarian cancer patients on seven different chemo-protocols
来源期刊:Acta PharmaceuticaDOI:10.2478/acph-2019-0002
Clinical testing of antiretroviral drugs as future prevention against vaginal and rectal transmission of HIV infection – a review of currently available results
来源期刊:Acta PharmaceuticaDOI:10.2478/acph-2019-0030
Actualities in the phytochemical research on selected terpenes
来源期刊:Acta PharmaceuticaDOI:10.2478/acph-2019-0036
AKR1D1*36 C>T (rs1872930) allelic variant is associated with variability of the CYP2C9 genotype predicted pharmacokinetics of ibuprofen enantiomers – a pilot study in healthy volunteers
来源期刊:Acta PharmaceuticaDOI:10.2478/acph-2019-0032
A modern approach to the treatment of plaque psoriasis
来源期刊:Acta PharmaceuticaDOI:10.2478/acph-2019-0047
Antiproliferative evaluation of various aminoquinoline derivatives
来源期刊:Acta PharmaceuticaDOI:10.2478/acph-2019-0048
Antiproliferative evaluation of various aminoquinoline derivatives
来源期刊:Acta PharmaceuticaDOI:10.2478/ACPH-2020-0048
Nutrition – facts and myths
来源期刊:Acta PharmaceuticaDOI:10.2478/acph-2019-0051
Identification of new process-related impurity in the key intermediate in the synthesis of TCV-116
来源期刊:Acta PharmaceuticaDOI:10.2478/acph-2019-0006

质量指标占比

研究类文章占比 OA被引用占比 撤稿占比 出版后修正文章占比
83.72%100%--

相关指数

影响因子
影响因子
年发文量
自引率

预警情况

查看说明
时间 预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
*来源:中科院《 国际期刊预警名单》

JCR分区

WOS分区等级:4区
版本 按学科 分区
WOS期刊SCI分区
WOS期刊SCI分区
WOS期刊SCI分区是指SCI官方(Web of Science)为每个学科内的期刊按照IF数值排 序,将期刊按照四等分的方法划分的Q1-Q4等级,Q1代表质量最高,即常说的1区期刊。
(2024-2025年最新版)
PHARMACOLOGY & PHARMACY
Q4

中科院分区

查看说明
版本 大类学科 小类学科 Top期刊 综述期刊
2026年3月发布
(新锐分区)
医学4区
PHARMACOLOGY & PHARMACY 药学
4区
N/A
2025年3月升级版
医学4区
PHARMACOLOGY & PHARMACY 药学
4区
2023年12月旧的升级版
医学4区
PHARMACOLOGY & PHARMACY 药学
4区

CiteScore

查看说明
CiteScore SJR SNIP 学科 分区 排名
4.50
0.398
0.607
大类:Pharmacology, Toxicology and Pharmaceutics 小类:Pharmacology
大类:Pharmacology, Toxicology and Pharmaceutics 小类:Pharmaceutical Science
Q2
Q2
161 / 321
78 / 185

相关文章